These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18533968)

  • 21. Dialysis for everybody? At any cost?
    Rombolà G
    J Nephrol; 2002; 15 Suppl 6():S33-42. PubMed ID: 12515372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A survey of views and practice patterns of dialysis medical directors toward end-of-life decision making for patients with end-stage renal disease.
    Fung E; Slesnick N; Kurella Tamura M; Schiller B
    Palliat Med; 2016 Jul; 30(7):653-60. PubMed ID: 26814215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invited article: Managing disruptive physician behavior: impact on staff relationships and patient care.
    Rosenstein AH; O'Daniel M
    Neurology; 2008 Apr; 70(17):1564-70. PubMed ID: 18427073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The medical director in integrated clinical care models.
    Parker TF; Aronoff GR
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1282-6. PubMed ID: 25352380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond the futility argument: the fair process approach and time-limited trials for managing dialysis conflict.
    Rinehart A
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):2000-6. PubMed ID: 23868900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment center characteristics associated with better outcomes: a role for the medical director?
    Spiegel BM
    Semin Dial; 2012 May; 25(3):296-8. PubMed ID: 22607212
    [No Abstract]   [Full Text] [Related]  

  • 27. Recommendations regarding conflict resolution and forgoing dialysis in special patient populations.
    Moss AH
    Nephrol News Issues; 2001 Dec; 15(13):51-4. PubMed ID: 12099239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can better understanding and use of treatment center performance feedback improve hemodialysis care? A role for the medical director.
    DeOreo PB; Wilson R; Wish JB
    Semin Dial; 2012 May; 25(3):290-3. PubMed ID: 22494265
    [No Abstract]   [Full Text] [Related]  

  • 29. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
    Bhat P; Sokolowski W; Bhat JG
    Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity of care and better outcomes among hemodialysis patients: a role for the Medical Director.
    Lacson E; Maddux FW
    Semin Dial; 2012 May; 25(3):299-302. PubMed ID: 22607213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Texas revises licensing rules for dialysis facilities.
    Payne GM
    Nephrol News Issues; 1999 May; 13(5):9. PubMed ID: 10578814
    [No Abstract]   [Full Text] [Related]  

  • 32. Withdrawal from dialysis in end-stage renal disease: medical, social, and psychological issues.
    Hackett AS; Watnick SG
    Semin Dial; 2007; 20(1):86-90. PubMed ID: 17244129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The medical director and quality requirements in the dialysis facility.
    Schiller B
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):493-9. PubMed ID: 25376762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical research: making it work in the outpatient dialysis facility.
    Doss S; Schiller B; Fox R; Moran J
    Nephrol Nurs J; 2009; 36(1):63-4. PubMed ID: 19271627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The decision making process of ESRD families during the dialysis withdrawal period].
    Lin TR
    Hu Li Za Zhi; 2011 Aug; 58(4):106-11. PubMed ID: 21809295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withdrawal from dialysis: ethical issues.
    Conneen S; Tzamaloukas AH; Adler K; Keller LK; Bordenave K; Murata GH
    Dial Transplant; 1998 Apr; 27(4):200, 202-4. PubMed ID: 16370109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical issues in treatment of patients with end-stage renal disease.
    Macklin R
    Soc Work Health Care; 1984; 9(4):11-20. PubMed ID: 6484783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(32):875-6. PubMed ID: 18701878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflict in teamwork: understanding roles and relationships.
    Lowe JI; Herranen M
    Soc Work Health Care; 1978; 3(3):323-30. PubMed ID: 382405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysis medical directors' role in maintaining quality of care and responsibility for facility-specific patient outcomes: evolution and current status.
    Goldman RS; Latos DL
    Semin Dial; 2012 May; 25(3):286-90. PubMed ID: 22607211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.